Parkin mediates the mitochondrial dysfunction through mRpL18
Journal of Biological Chemistry · 2025-06 · 301 (6) · 110208
DOI: 10.1016/j.jbc.2025.110208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-06. Verfasst von Xiuxiu Ti und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Jiangsu Key Laboratory of Molecular M…. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Drosophila Proteins, Drosophila melanogaster, Mitochondrial Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, National Institute of Genetics.
Abstract (Originalsprache)
Loss of function of parkin leads to mitochondrial dysfunction, which is closely related to Parkinson's disease. However, the in vivo mechanism is far from clear. One dogma is that impaired Parkin causes dysfunction of mitophagy mediated by Pink1-Parkin axis. The other is that impaired Parkin causes Mfn accumulation which leads to mitochondrial dysfunction. Surprisingly, in Drosophila muscles, the first dogma is not applicable; for the second dogma, our study suggests that Parkin mediates mitochondrial dysfunction through the synergy of both Marf and mitochondrial protein mRpL18 got from our genome-wide screen, whose RNAi rescues parkin RNAi phenotype. Mechanistically, we found that impaired Parkin upregulated both transcription and protein levels of mRpL18 dependent on its E3 ligase activity, causing mRpL18 accumulation outside mitochondria. Consequently, cytosolic-accumulated mRpL18 competitively bound Drp1, leading to the reduction of the binding of Drp1 to its receptor Fis1, which finally inhibited mitochondrial fission and tipped the balance to mitochondrial hyperfusion, thereby affected the mitochondrial function. Taken together, our study suggests that impaired Parkin causes mitochondrial hyperfusion due to two reasons: (1) Parkin defect impairs Pink1-Parkin axis-mediated Marf degradation, which promotes mitochondrial fusion; (2) Parkin defect causes mRpL18 accumulation, which inhibits Drp1/Fis1-mediated mitochondrial fission. These two ways together drive Parkin-mediated mitochondrial hyperfusion. Therefore, knockdown of either marf or mRpL18 can prevent mitochondrial hyperfusion, leading to the rescue of Parkin defect-triggered fly wing phenotypes. Overall, our study unveils a new facet of how Parkin regulates mitochondrial morphology, which provides new insights for the understanding and treatment of Parkinson's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Jiangsu Key Laboratory of Molecular Medicine, Model Animal Research Center, School of Medicine, Nanjing Uni…
- Department of Cardiovascular Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
- Key Laboratory of Developmental Genes and Human Disease, School of Life Science and Technology, School of Medicine, Southeast University, Nanjing, China.
- Key Laboratory of Developmental Genes and Human Disease, School of Life Science and Technology, School of Medicine, Southeast University, Nanjing, China. Electronic address: ganguangm@seu.edu.cn.
- Department of Cardiovascular Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China. Electronic address: wangyan4127@bjhmoh.cn.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- National Institute of Genetics
- University of Iowa
Zitieren
APA
Ti, X., Zuo, H., Zhao, G., Li, Y., Du, M., Xu, L., Li, S., Shan, Z., Gao, Y., Gan, G., Wang, Y., & Zhang, Q. (2025). Parkin mediates the mitochondrial dysfunction through mRpL18. Journal of Biological Chemistry, 301(6), 110208. https://doi.org/10.1016/j.jbc.2025.110208
Vancouver
Ti X, Zuo H, Zhao G, Li Y, Du M, Xu L, et al. Parkin mediates the mitochondrial dysfunction through mRpL18. Journal of Biological Chemistry. 2025;301(6):110208. doi:10.1016/j.jbc.2025.110208
BibTeX
@article{Ti2025,
author = {Ti, Xiuxiu and Zuo, Hui and Zhao, Guochun and Li, Yuwei and Du, Minghui and Xu, Liwen and Li, Shengnan and Shan, Zhaoliang and Gao, Yuxue and Gan, Guangming and Wang, Yan and Zhang, Qing},
title = {Parkin mediates the mitochondrial dysfunction through mRpL18},
journal = {Journal of Biological Chemistry},
year = {2025},
volume = {301},
number = {6},
pages = {110208},
doi = {10.1016/j.jbc.2025.110208}
}
EUVIMED